RBC Capital raised the firm’s price target on MannKind (MNKD) to $7 from $5 and keeps a Sector Perform rating on the shares. The company reported another strong quarter with total revenues up 37%, continued pull-through of Tyvaso DPI royalty and collaboration revenues, and appreciable Afrezza performance, supporting the topline, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNKD:
